Snapshot from Jul 25, 2026 at 07:00 UTC. For live data and tracking: View Live
Tech medical breakthrough

India Develops Placenta-on-Chip

Analysis based on 8 articles · First reported Jul 04, 2026 · Last updated Jul 04, 2026

Sentiment
70
Attention
4
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The development of the placenta-on-chip technology by India — ICMR-National Institute for Research in Reproductive Health and IIT Bombay is expected to positively impact the biotechnology and pharmaceutical industries by providing a more efficient and ethical platform for drug testing and understanding pregnancy complications. This could lead to faster development of safer medications for pregnant women and improved maternal and fetal health outcomes, potentially reducing costs associated with animal testing.

Biotechnology Pharmaceuticals Healthcare

Indian scientists from India — ICMR-National Institute for Research in Reproductive Health and IIT Bombay have developed a groundbreaking 'placenta-on-chip' technology. This lab-grown model replicates key functions of the human placenta, offering a novel platform to study pregnancy, understand complications like gestational diabetes, and evaluate drug safety. The simple, scalable design aims for widespread adoption in research, potentially reducing reliance on animal testing. Key figures like Deepak Modi, Anshul Bhide, and Abhijit Majumdar were instrumental in its development and validation. This innovation strengthens India's capabilities in biomedical research and aligns with global efforts for human-relevant research models.

govactor
India — ICMR-National Institute for Research in Reproductive Health, now known as ICMR-NIRWoH, collaborated with IIT Bombay to develop the placenta-on-chip technology, significantly advancing its research capabilities in women's and reproductive health.
Importance 90.0 Sentiment 70.0
cnt
India has strengthened its capabilities in biomedical innovation and aligned with global efforts to develop predictive alternatives to animal experimentation through the development of the placenta-on-chip platform.
Importance 80.0 Sentiment 60.0
per
Deepak Modi, a scientist at ICMR-NIRWoH and co-corresponding author, emphasized the importance of the placenta-on-chip in understanding pregnancy and reducing animal experimentation.
Importance 70.0 Sentiment 60.0
per
Anshul Bhide led the biological validation of the placenta-on-chip system, demonstrating its potential for studying pregnancy complications like gestational diabetes.
Importance 70.0 Sentiment 60.0
per
Abhijit Majumdar, a professor at IIT Bombay and co-corresponding author, guided the engineering design and fabrication of the platform, aiming for its widespread adoption.
Importance 70.0 Sentiment 60.0
per
Mukherjee, a co-author, highlighted the crucial role of interdisciplinary collaboration in developing advanced human-relevant models like the placenta-on-chip.
Importance 60.0 Sentiment 50.0
per
Geetanjali Sachdeva, Director of ICMR-NIRWoH, affirmed the institute's commitment to innovative solutions for women's and reproductive health through projects like the placenta-on-chip.
Importance 60.0 Sentiment 50.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.